Environmental RF | Country | Years | Cases | Diagnosis | Outcome summary | Significant | Author |
Seasons and annual cyclic trends | |||||||
Seasons | Australia | 1992–2011 | 314 | TAB | Summer (January/December) month increased incidence (p=0.015) | Yes | Dunstan et al 37 |
Seasons and infection | Denmark | 1982–1994 | – | TAB and clinical | Quarterly and annual fluctuations seen (association with infectious epidemics) | Yes | Elling et al 10 |
Seasons | France | 1983–1995 | 109 | TAB and clinical | No seasonal variation but peak in December | No | Ramassamy et al 40 |
Seasons | France | 1993 | 213 | – | No seasonal pattern | No | Raynauld et al 41 |
Seasons | Israel | 1980–2004 | 210 | TAB and ACR | Incidence more common late spring/early summer (p<0.001) | Yes | Bas-Lando et al 9 |
Seasons | Israel | 1980–1991 | 84 | TAB | Incidence more common during May to June (p<0.0005) | Yes | Sonnenblick et al 20 |
Seasons | NZ | 1996–2005 | 70 | TAB | Incidence greatest in spring (p<0.9) | No | Abdul-Rahman et al 8 |
Seasons | Spain | 1981–2005 | 255 | TAB | No seasonal pattern over 25 years | No | Gonzalez-Gay et al 33 |
Seasons | Spain | 1976–2001 | 184 | TAB and clinical | No cyclic or seasonal pattern of variation | No | Liozon et al 39 |
Seasons and cycles | Spain | 1981–1999 | 161 | TAB | No seasonal or annual incidence pattern seen in the Lugo region | No | Gonzalez-Gay et al 42 |
Season | Spain | 1985–1997 | 143 | – | No seasonal variation | No | Narváez et al 43 |
Seasons | Sweden | 1997–2010 | 840 | TAB | No seasonal or significant monthly variation | No | Mohammad et al 44 |
Seasons and cycles | Sweden | 1976–1995 | 665 | TAB | Random annual trends. Season predominance in winter and autumn (p=0.041) | Yes | Petursdottir et al 18 |
Seasons and cycles | USA | 1994–2011 | 215 | TAB | No significant fluctuations in the annual or monthly data (p=0.55). | No | Kisza et al 45 |
Seasons and cycles | USA | 1950–1999 | 173 | TAB and ACR | Cyclic incidence peaks 7–10 yearly, last ~3 years. No significant seasonal pattern | No | Salvarani et al 46 |
Latitude | |||||||
Latitude | Norway | 1992–1996 | 70 | TAB and ACR | No incidence difference between Northern and Southern Norway | No | Haugeberg et al 21 |
Latitude (and seasons) | UK | 1990–2001 | 3928 | Clinical (GPRD) | Incidence in South-North (UK), and greater in summer months (p=0.0022) | Yes | Smeeth et al 13 |
Altitude | |||||||
Altitude | Spain | 1981–2001 | – | TAB | Altitude had no effect on incidence of GCA (altitude ranged from 100 to 952 m) | No | Llorca et al 23 |
Solar cycle and sunlight | |||||||
Solar and geomagnetic | USA | 1950–2004 | – | – | Geomagnetic activity may explain temporal variation and east-west skewness | Yes | Wing et al 26 |
Solar exposure | Australia | 1997 | 2 | Skin biopsy | Solar aetiology: link between actinic granulomas and GCA of subcutaneous vessels | – | Lau et al 47 |
Solar exposure | Australia | 1987 | 4* | Clinical and TAB | Observations: actinic radiation=vascular risk factor (elastotic/lytic properties) | – | O’Brien48 |
Solar exposure | UK | 1965 | 60 | Clinical | Sun exposure may cause GCA (14/18 cases sun exposed). Incidence up in June | – | Kinmont and McCallum19 |
SES | |||||||
Occupation and SES | Sweden | 1964–2008 | 8019 | Hospital register | Education, marital status, SES, occupation only weakly associated with GCA | No | Zöller et al 22 |
SES | UK | 2005–2009 | 271 | TAB and ACR | Area-level socioeconomic deprivation associated with ischaemia from GCA. | Yes | Mackie et al 29 |
SES, sunlight, infection | France | 1970–1979 | 94 | – | Environmental factors (sun exposure, lifestyle, SES) do not affect incidence | No | Barrier et al 49 |
Urban versus rural | |||||||
Urban versus rural | Germany | 1994 | 79 | ACR | GCA was more common in the urban than in the rural populations | Yes | Reinhold-Keller et al 30 |
Symbol (–) denotes unable to complete this information.
*Observational study with numbers not well defined.
ACR, American College of Rheumatology; GCA, giant cell arteritis; GPRD, General Practice Research Database; NZ, New Zealand; RF, risk factors; SES, socioeconomic status; TAB, temporal artery biopsy.